The Medicines and Healthcare products Regulatory Agency (MHRA) has successfully completed an inspection of Almac’s Clinical Services UK facility in Craigavon. The routine inspection concluded that the site continues to be compliant with EU Good Manufacturing Practices, with no critical or major failures observed.

Paul O’Connor, vice president of quality at Almac, said, “We are extremely pleased with the outcome of our inspection. These successful results are a positive reflection of all the investment Almac has made over the past few years in our facilities and recruitment of the best employees, ensuring that we are a market leader and continue to deliver a high quality service. Quality is at the core of our ethos. The very high standards of quality compliance will continue with our new $120 million North American Headquarters in Souderton, which is scheduled to open in the fall.”

Click here to learn more about Almac’s services.